Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.08T | 1.08T | 1.02T | 1.00T | 888.67B | 806.63B |
Gross Profit | 231.53B | 231.53B | 220.27B | 200.08B | 199.11B | 180.90B |
EBITDA | 108.17B | 124.30B | 115.51B | 99.00B | 104.64B | 86.49B |
Net Income | 49.08B | 49.08B | 44.36B | 40.14B | 43.21B | 27.37B |
Balance Sheet | ||||||
Total Assets | 1.25T | 1.25T | 1.22T | 1.09T | 1.02T | 926.82B |
Cash, Cash Equivalents and Short-Term Investments | 70.61B | 70.61B | 64.97B | 72.09B | 64.88B | 50.57B |
Total Debt | 418.23B | 418.23B | 418.72B | 366.73B | 346.50B | 307.51B |
Total Liabilities | 713.29B | 713.29B | 714.21B | 645.16B | 602.17B | 554.43B |
Stockholders Equity | 517.14B | 517.14B | 488.56B | 430.23B | 395.13B | 357.80B |
Cash Flow | ||||||
Free Cash Flow | 25.76B | 25.76B | 16.16B | -9.72B | 25.24B | 24.57B |
Operating Cash Flow | 93.24B | 93.24B | 79.63B | 56.95B | 71.57B | 76.60B |
Investing Cash Flow | -62.17B | -62.17B | -97.97B | -71.14B | -53.15B | -52.70B |
Financing Cash Flow | -27.34B | -27.34B | 14.72B | 19.26B | -6.62B | -20.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | 371.33B | 8.82 | 13.75% | 4.06% | 1.29% | -22.20% | |
76 Outperform | $592.55B | 11.89 | 10.06% | 2.44% | 4.35% | 7.88% | |
74 Outperform | 276.04B | 12.19 | 5.36% | 3.00% | 3.80% | -11.14% | |
71 Outperform | 532.51B | 12.86 | 6.82% | 3.36% | -6.27% | 40.98% | |
68 Neutral | 630.61B | 18.48 | 13.10% | 1.68% | 4.89% | -3.79% | |
67 Neutral | 707.11B | 46.77 | 1.82% | 4.02% | -0.91% | -74.07% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Air Water Inc. has announced a tender offer to acquire all shares of Ci Medical Co., Ltd., aiming to privatize the company. The tender offer is supported by Ci Medical’s board and involves a significant agreement with its largest shareholder, Mr. Kiyoto Shimizu, to consolidate ownership and facilitate the acquisition process.
Air Water Inc. has announced a company split to transfer part of its industrial gas business to its subsidiary, Air Water Gas Products Inc., effective October 1, 2025. This move aims to streamline operations and strengthen the company’s position in the expanding electronics-related gas sector, while also focusing on global expansion.
Air Water Inc. has completed the payment procedures for the disposal of its treasury shares as restricted stock compensation, initially resolved by the Board of Directors on July 9, 2025. This move involves the disposal of 60,673 shares at a price of 2,191.5 yen per share, totaling 132,964,880 yen, and is aimed at compensating directors and executive officers, potentially impacting the company’s stock management and executive incentives.
Air Water Inc. has announced the disposal of treasury shares as part of a restricted stock compensation plan aimed at aligning the interests of its directors and executives with those of shareholders. This move is expected to enhance corporate value and motivate key personnel by tying their compensation to the company’s stock performance, with a minimal dilution impact on existing shares.
Air Water Inc. has announced its ‘terrAWell30 2nd stage’ medium-term management plan for FY2025-2027, shifting focus from expanding scale to pursuing profitability. The company plans to review existing businesses, invest in growth sectors, and improve low-growth areas to double its market capitalization by FY2030, enhancing its position for sustainable growth.